Press Releases from DelveInsight Business Research (5349 total)
Fanconi Anemia Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Thera …
(Albany, United States) "Fanconi Anemia Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the…
Clostridium Difficile Infections Clinical Trials 2025: EMA, PDMA, FDA Approvals, …
(Albany, United States) As per DelveInsight's assessment, globally, Clostridium Difficile Infections pipeline constitutes 20+ key companies continuously working towards developing 22+ Clostridium Difficile Infections treatment…
Limbal Stem Cells Deficiency Market to Reach New Heights in Growth by 2034, Delv …
DelveInsight's "Limbal Stem Cells Deficiency Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Limbal Stem Cells Deficiency, historical and forecasted…
Bunion Pipeline 2025: Mechanism of Action, Route of Administration, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Bunion pipeline constitutes key companies continuously working towards developing Bunion treatment therapies, analysis of…
Persistent Epithelial Defect Market on Track for Major Expansion by 2034, Accord …
DelveInsight's "Persistent Epithelial Defect Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Persistent Epithelial Defect, historical and forecasted epidemiology as…
Post-operative Cataract Surgery Inflammation Market Growth Projections 2024-2034 …
DelveInsight's "Post-operative Cataract Surgery Inflammation Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Post-operative Cataract Surgery Inflammation, historical and forecasted…
Neurotrophic Keratopathy Market to Expand Significantly by 2032, States DelveIns …
DelveInsight's "Neurotrophic Keratopathy Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Neurotrophic Keratopathy, historical and forecasted epidemiology as well as…
Hemorrhagic Cystitis Treatment Market 2032: EMA, PDMA, FDA Approvals, Medication …
(Albany, USA) DelveInsight's "Hemorrhagic Cystitis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Hemorrhagic Cystitis, historical and forecasted epidemiology as…
Multiple Organ Dysfunction Syndrome Treatment Market 2032: EMA, PDMA, FDA Approv …
(Albany, USA) DelveInsight's "Multiple Organ Dysfunction Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Multiple Organ Dysfunction Syndrome, historical…
Congenital Hyperinsulinism Drugs Market 2034: EMA, PDMA, FDA Approvals, Medicati …
(Albany, USA) DelveInsight's "Congenital Hyperinsulinism Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Congenital Hyperinsulinism, historical and forecasted epidemiology as…
Sialorrhea Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical …
(Albany, USA) DelveInsight's "Sialorrhea Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of Sialorrhea epidemiology, market, and clinical development in…
Levodopa-Induced Dyskinesia Drugs Market 2032: EMA, PDMA, FDA Approvals, Medicat …
(Albany, USA) DelveInsight's "Levodopa-Induced Dyskinesia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Levodopa-Induced Dyskinesia, historical and forecasted epidemiology as…
Lambert-Eaton Myasthenic Syndrome Treatment Market 2034: EMA, PDMA, FDA Approval …
(Albany, USA) DelveInsight's "Lambert-Eaton Myasthenic Syndrome Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of Lambert-Eaton Myasthenic Syndrome epidemiology, market,…
Treatment-Resistant Depression Treatment Market 2032: EMA, PDMA, FDA Approvals, …
(Albany, USA) DelveInsight's "Treatment Resistant Depression Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of historical and forecasted epidemiology as…
Atherosclerotic Cardiovascular Disease Market Predicted to See Upsurge Through 2 …
DelveInsight's "Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Atherosclerotic Cardiovascular Disease, historical and forecasted epidemiology…
Intrahepatic Cholangiocarcinoma Pipeline 2025: Mechanism of Action, Route of Adm …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Intrahepatic Cholangiocarcinoma pipeline constitutes 18+ key companies continuously working towards developing 20+ Intrahepatic Cholangiocarcinoma…
Leptomeningeal Metastases Pipeline 2025: Key Companies, MOA, ROA, and Clinical T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Leptomeningeal Metastases pipeline constitutes 5+ key companies continuously working towards developing 5+ Leptomeningeal Metastases…
Liver Cirrhosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emergi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Liver Cirrhosis pipeline constitutes 30+ key companies continuously working towards developing 30+ Liver Cirrhosis…
Major Depressive Disorder Market Growth to Accelerate in Forecast Period (2024-2 …
DelveInsight's "Major Depressive Disorder Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Major Depressive Disorder, historical and forecasted epidemiology as…
Acute Coronary Syndrome Treatment Market 2034: EMA, PDMA, FDA Approvals, Medicat …
(Albany, USA) DelveInsight's Acute Coronary Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, acute coronary syndrome emerging drugs, market share of…
Pulmonary Arterial Hypertension Treatment Market 2034: EMA, PDMA, FDA Approvals, …
(Albany, USA) DelveInsight's comprehensive report, Pulmonary Arterial Hypertension - Market Insight, Epidemiology, and Market Forecast - 2034, provides a detailed analysis of the current and…
Polycythemia Treatment Market 2032: EMA, PDMA, FDA Approvals, Medication, Clinic …
(Albany, USA) DelveInsight's "Polycythemia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Polycythemia, historical and forecasted epidemiology as well as…
Myelofibrosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE …
(Albany, USA) DelveInsight's "Myelofibrosis Market Insights, Epidemiology, and Market Forecast 2034" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well…
Hemophilia Treatment Market 2032: EMA, PDMA, FDA Approvals, Medication, NICE App …
(Albany, USA) DelveInsight's "Hemophilia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemophilia, historical and forecasted epidemiology as well as…
Thrombotic Thrombocytopenic Purpura Treatment Market 2034: EMA, PDMA, FDA Approv …
(Albany, USA) DelveInsight's "Thrombotic Thrombocytopenic Purpura Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Thrombotic Thrombocytopenic Purpura, historical and forecasted…
Anti-CD19 Antibody Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, United States) As per DelveInsight's assessment, globally, Anti-CD19 Antibody pipeline constitutes key companies continuously working towards developing Anti-CD19 Antibody treatment therapies, analysis of Clinical…
Bardet-Biedl Syndrome Treatment Market 2034: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, USA) DelveInsight's "Bardet-Biedl Syndrome Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Bardet-Biedl Syndrome, historical and forecasted epidemiology as well…
Myelodysplastic Syndrome Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medicat …
(Albany, USA) DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It…
Thrombocytopenia Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, The …
(Albany, United States) As per DelveInsight's assessment, globally, Thrombocytopenia pipeline constitutes 25+ key companies continuously working towards developing 25+ Thrombocytopenia treatment therapies, analysis of Clinical…
Thrombotic Thrombocytopenic Purpura Market Forecasted to Surge in Coming Years, …
DelveInsight's "Thrombotic Thrombocytopenic Purpura Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Thrombotic Thrombocytopenic Purpura, historical and forecasted epidemiology as…
Paroxysmal Nocturnal Hemoglobinuria Market Expected to Experience Major Growth b …
DelveInsight's "Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Paroxysmal Nocturnal Hemoglobinuria, historical and forecasted epidemiology as…
Steroid Refactory Acute Graft-Versus-Host Disease Market Set to Grow Substantial …
market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly…
Graves Ophthalmopathy Market to Show Remarkable Growth Trends from 2024 to 2034, …
The Graves Ophthalmopathy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Graves…
Systemic Scleroderma Market Predicted to See Upsurge Through 2032, Highlights De …
DelveInsight's "Systemic Scleroderma Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Systemic Scleroderma, historical and forecasted epidemiology as well as…
Food Allergy Drugs Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical T …
(Albany, USA) DelveInsight's Food Allergy Market Insights report includes a comprehensive understanding of current treatment practices, food allergy emerging drugs, market share of individual therapies,…
Alcohol Use Disorder Drugs Market 2034: EMA, PDMA, FDA Approvals, Medication, Cl …
(Albany, USA) DelveInsight's Alcohol Use Disorder Market Insights report includes a comprehensive understanding of current treatment practices, emerging alcohol use disorder drugs, market share of…
IgG4-Related Disease Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, IgG4-Related Disease pipeline constitutes 10+ key companies continuously working towards developing 10+ IgG4-Related Disease treatment therapies, analysis…
MRNA Based Vaccines and Therapeutics Market 2032: EMA, PDMA, FDA Approvals, Medi …
(Albany, USA) DelveInsight's "MRNA Based Vaccines and Therapeutics Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the MRNA Based Vaccines and…
Bone and Joint Infection Treatment Market 2032: EMA, PDMA, FDA Approvals, Medica …
(Albany, USA) DelveInsight's "Bone and Joint Infection - Market Insight, Epidemiology, And Market Forecast - 2032′′ report offers an in-depth understanding of the Bone and…
Diabetic Macular Edema Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) "Diabetic Macular Edema Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Pulmonary Sarcoidosis Market to Reach New Heights in Growth by 2032, DelveInsigh …
The Pulmonary Sarcoidosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pulmonary…
Social Anxiety Disorder Market Growth to Accelerate in Forecast Period (2023-203 …
DelveInsight's "Social Anxiety Disorder Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Social Anxiety Disorder, historical and forecasted epidemiology as…
Carpal Tunnel Syndrome Market to Expand Significantly by 2032, States DelveInsig …
The Carpal Tunnel Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Schizophrenia Market Growth Projections 2024-2034: DelveInsight Analysis | Reviv …
DelveInsight's "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Schizophrenia, historical and forecasted epidemiology as well as the Schizophrenia…
Dysautonomia Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by D …
DelveInsight's "Dysautonomia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Dysautonomia, historical and forecasted epidemiology as well as the Dysautonomia…
Lupus Nephritis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, United States) "Lupus Nephritis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the…
Cough in Idiopathic Pulmonary Fibrosis Clinical Trials 2025: EMA, PDMA, FDA Appr …
(Las Vegas, Nevada, United States) "Cough in Idiopathic Pulmonary Fibrosis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario…
Nontuberculous Mycobacterial Infections Clinical Trials 2025: EMA, PDMA, FDA App …
(Albany, United States) As per DelveInsight's assessment, globally, Nontuberculous Mycobacterial Infections pipeline constitutes 10+ key companies continuously working towards developing 10+ Nontuberculous Mycobacterial Infections treatment…
Hyperuricemia Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therap …
(Albany, United States) "Hyperuricemia Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hyperuricemia…
Hepatitis D Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapie …
(Albany, United States) As per DelveInsight's assessment, globally, Hepatitis D pipeline constitutes 6+ key companies continuously working towards developing 6+ Hepatitis D treatment therapies, analysis…
